Thu, August 11, 2022
Wed, August 10, 2022
Tue, August 9, 2022
Mon, August 8, 2022

Luca Issi Maintained (ALLO) at Buy with Decreased Target to $32 on, Aug 10th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-32-on-aug-10th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Luca Issi of RBC Capital, Maintained "Allogene Therapeutics, Inc." (ALLO) at Buy with Decreased Target from $35 to $32 on, Aug 10th, 2022.

Luca has made no other calls on ALLO in the last 4 months.



There are 2 other peers that have a rating on ALLO. Out of the 2 peers that are also analyzing ALLO, 1 agrees with Luca's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jack Allen of "Baird" Initiated at Hold and Held Target at $11 on, Friday, June 3rd, 2022


This is the rating of the analyst that currently disagrees with Luca


  • Salveen Richter of "Goldman Sachs" Upgraded from Hold to Strong Buy and Increased Target to $32 on, Friday, July 15th, 2022

Publication Contributing Sources